AbbVie (ABBV)

$163.79 2.98 (1.85%)

19:00 EDT ABBV Stock Quote Delayed 30 Minutes

7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 30, 2024

Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.

Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing

ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024

Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 5.85M

Day's Range $160.74 - $164.25

52-Week Range $130.96 - $182.89

Dividend & Yield $5.92 (3.61%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Apr 16, 2024

Blue-chip dividend stocks have always been relevant. While they’re not the most exciting investments, they provide a steady hand during market uncertainty. This attribute has…

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year

By Alex Sirois, InvestorPlace Contributor Apr 4, 2024

These seven dividend stocks provide a base for $50,000 in income per year for dedicated investors with patience.

The 3 Best Stocks to Buy in April 2024

By Josh Enomoto, InvestorPlace Contributor Apr 2, 2024

The big money might be feeling a bit queasy about overexposure to risk-on assets, presenting a framework to follow regarding the best stocks to buy…

Long Live the Dividend Kings: 3 Top Picks to Build an Income Portfolio

By Alex Sirois, InvestorPlace Contributor Mar 28, 2024

The dividend kings are excellent stocks with which to establish an income portfolio with these three dividend king stocks standing out.

Why Is Landos Biopharma (LABP) Stock Up 168% Today?

By William White, InvestorPlace Writer Mar 25, 2024

Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.

SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster

By Rich Duprey, InvestorPlace Contributor Mar 13, 2024

With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.

3 Must-Have Dividend Kings for a Steady Income Stream

By Yiannis Zourmpanos, InvestorPlace Contributor Mar 12, 2024

Discover the dividend kings with constant growth, dominating pharmaceuticals, household products and biotechnology industries.

Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What

By Josh Enomoto, InvestorPlace Contributor Mar 11, 2024

At first glance, another gangbusters jobs report seems to imply that dividend stocks are irrelevant. It’s all about growth, baby! Well, maybe not. According to…

3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024

By Muslim Farooque, InvestorPlace Contributor Mar 9, 2024

Dive into the world of three unstoppable mega-cap stocks leading the charge amidst the bullishness in the market.

3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates

By Rich Duprey, InvestorPlace Contributor Mar 6, 2024

These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns.

The Top 7 Dividend Stocks to Buy in March 2024

By Muslim Farooque, InvestorPlace Contributor Mar 6, 2024

Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance.

Secure Your Future: 7 Dividend Kings with Solid Growth Potential

By Chris Markoch, InvestorPlace Contributor Mar 4, 2024

Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends.

Blue-Chip Backbone: 3 Stocks for Unwavering Market Strength

By Chris Markoch, InvestorPlace Contributor Feb 29, 2024

With many shiny objects to distract you, it takes patience to ride your blue-chip stocks higher, but these three stocks continue to deliver.

3 Cash Cows to Boost Your Confidence During the February Chill

By Josh Enomoto, InvestorPlace Contributor Feb 18, 2024

What are cash cow stocks? If “Jeopardy!” ever broadcasted a category called “Market Downturn,” this may be your answer (in the form of question). By…

The 7 Best Momentum Stocks You Can Purchase Today

By Alex Sirois, InvestorPlace Contributor Feb 12, 2024

Momentum stocks require a positive mindset with and an ability to catch a hot company while it moves higher

3 Stocks Just Hit New 52-Week Highs. Should You Still Be Buying?

By Rich Duprey, InvestorPlace Contributor Feb 8, 2024

Letting your winners run can generate portfolio returns without cutting them off by taking profits. Check out these stocks with 52-week highs.

7 Dividend Stocks Worth Holding for the Long Haul

By Alex Sirois, InvestorPlace Contributor Feb 6, 2024

These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

By Alex Sirois, InvestorPlace Contributor Jan 31, 2024

Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves.

3 Dividend Stars Every Investor Should Own to Survive a Market Crash

By Rich Duprey, InvestorPlace Contributor Jan 24, 2024

Prepare for the worst but hope for the best by buying dividend stocks for a market crash that can provide both growth and income.

AbbVie (ABBV)

7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns

Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing

ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024

Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AbbVie (ABBV)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABBV Stock Predictions, Articles, and AbbVie News

Subscriber Sign in